Have a feature idea you'd love to see implemented?
Let us know!
NVOS Novo Integrated Sciences Inc
Price (delayed)
$0.2496
Market cap
$4.76M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.28
Enterprise value
$7.46M
Novo Integrated Sciences, Inc. is a U.S. based provider of multidisciplinary primary care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science. The company
Highlights
The debt has declined by 14% since the previous quarter
The net income has plunged by 101% from the previous quarter but it has grown by 25% YoY
NVOS's EPS has shrunk by 100% QoQ but it has soared by 86% YoY
The gross margin has dropped by 89% year-on-year and by 6% since the previous quarter
NVOS's equity has dropped by 63% year-on-year and by 55% since the previous quarter
Key stats
What are the main financial stats of NVOS
Market
Valuations
Earnings
Shares outstanding
19.05M
Market cap
$4.76M
Enterprise value
$7.46M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.48
Price to sales (P/S)
0.35
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.55
Revenue
$13.52M
EBIT
-$23.75M
EBITDA
-$20.83M
Free cash flow
-$4.78M
Per share
Balance sheet
Liquidity
EPS
-$1.28
Free cash flow per share
-$0.26
Book value per share
$0.52
Revenue per share
$0.72
TBVPS
$0.7
Total assets
$35.33M
Total liabilities
$25.66M
Debt
$4.24M
Equity
$9.96M
Working capital
-$16.52M
Debt to equity
0.43
Current ratio
0.27
Quick ratio
0.21
Net debt/EBITDA
-0.13
Margins
Efficiency
Dividend
EBITDA margin
-154.1%
Gross margin
37.7%
Net margin
-180%
Operating margin
-77.5%
Return on assets
-68%
Return on equity
-120.8%
Return on invested capital
-753.5%
Return on capital employed
-187.7%
Return on sales
-175.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NVOS stock price
How has the Novo Integrated Sciences stock price performed over time
Intraday
3.7%
1 week
-15.1%
1 month
-17.08%
1 year
-94.33%
YTD
-69.6%
QTD
-11.17%
Financial performance
How have Novo Integrated Sciences's revenue and profit performed over time
Revenue
$13.52M
Gross profit
$5.09M
Operating income
-$10.47M
Net income
-$24.33M
Gross margin
37.7%
Net margin
-180%
The net margin has dropped by 103% since the previous quarter but it has soared by 94% year-on-year
The net income has plunged by 101% from the previous quarter but it has grown by 25% YoY
Novo Integrated Sciences's operating margin has surged by 97% YoY but it has decreased by 13% QoQ
The gross margin has dropped by 89% year-on-year and by 6% since the previous quarter
Growth
What is Novo Integrated Sciences's growth rate over time
Valuation
What is Novo Integrated Sciences stock price valuation
P/E
N/A
P/B
0.48
P/S
0.35
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.55
NVOS's EPS has shrunk by 100% QoQ but it has soared by 86% YoY
NVOS's equity has dropped by 63% year-on-year and by 55% since the previous quarter
The price to book (P/B) is 52% lower than the last 4 quarters average of 1.0
The P/S is 71% below the last 4 quarters average of 1.2
Efficiency
How efficient is Novo Integrated Sciences business performance
Novo Integrated Sciences's ROE has plunged by 143% from the previous quarter but it has increased by 10% YoY
The ROIC has plunged by 120% YoY
NVOS's ROS has shrunk by 105% QoQ but it has soared by 94% YoY
The company's return on assets has shrunk by 102% QoQ but it rose by 21% YoY
Dividends
What is NVOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NVOS.
Financial health
How did Novo Integrated Sciences financials performed over time
The total assets is 38% more than the total liabilities
Novo Integrated Sciences's total liabilities has surged by 171% YoY and by 97% QoQ
The current ratio has dropped by 58% year-on-year and by 46% since the previous quarter
The debt is 57% smaller than the equity
The company's debt to equity has surged by 169% YoY and by 95% QoQ
NVOS's equity has dropped by 63% year-on-year and by 55% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.